Ligand validation:3QAK

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3QAK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3QAK_OLC_A_1201	24%	33%	0.139	0.858	1.51	1.15	1	2	0	0	48%	1
3QAK_OLC_A_1202	21%	35%	0.156	0.853	1.43	1.13	1	1	1	0	52%	1
8JWZ_OLC_A_521	19%	54%	0.212	0.807	0.8	0.97	2	1	0	0	100%	1
5WF6_OLC_A_1202	11%	60%	0.287	0.918	0.52	0.98	-	-	2	0	36%	1
5WF5_OLC_A_1202	9%	61%	0.273	0.83	0.51	0.97	-	1	0	0	60%	1
8JWY_OLC_A_1219	7%	43%	0.313	0.768	0.98	1.24	1	2	3	0	100%	1
9F9J_OLC_A_307	100%	42%	0.034	0.981	1.05	1.18	1	2	0	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
9F9D_OLC_A_308	67%	42%	0.081	0.887	0.96	1.29	1	3	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	4	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.